Profile data is unavailable for this security.
About the company
Shanghai Bio-heart Biological Technology Co Ltd is a China-based company mainly engaged in the business of interventional instruments. The Company's main businesses are the development and production of interventional cardiovascular devices. The Company's main products comprise fully bioresorbable scaffolds (BRS) and renal denervation (RDN). The Company's products are mainly used to meet medical needs for the treatment of coronary, peripheral artery disease and hypertension. The Company's products are used in addressing the unmet medical needs of Chinese patients for the treatment of coronary artery diseases and the unmet medical needs of patients for the treatment of uncontrolled hypertension. The Company mainly conducts its businesses in the domestic market and overseas markets.
- Revenue in HKD (TTM)23.60m
- Net income in HKD-101.06m
- Incorporated2014
- Employees70.00
- LocationShanghai Bio-heart Biological Technology Co LtdRoom 302, 3/F, Building 4No.590 Ruiqing Road, East ZhangjiangHi-Tech Park, Pudong New AreaSHANGHAI 2012201ChinaCHN
- Phone+86 2 168798511
- Fax+86 2 168798512
- Websitehttp://www.bio-heart.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vincent Medical Holdings Ltd | 869.70m | 87.51m | 672.45m | 1.46k | 7.50 | 1.07 | 5.19 | 0.7732 | 0.136 | 0.136 | 1.35 | 0.9542 | 0.9226 | 3.30 | 3.96 | 654,893.10 | 9.72 | 10.32 | 13.97 | 14.95 | 34.47 | 34.77 | 10.53 | 10.25 | 1.55 | -- | 0.2049 | 37.10 | 11.56 | 9.79 | 20.76 | 43.10 | 26.32 | 24.57 |
| BioSino Bio-technology and Science Inc | 254.61m | -53.54m | 810.36m | 471.00 | -- | 4.78 | -- | 3.18 | -0.37 | -0.37 | 1.76 | 1.17 | 0.4633 | 2.41 | 1.59 | 510,237.40 | -12.66 | -2.01 | -33.54 | -5.46 | 38.77 | 39.79 | -27.32 | -3.72 | 0.7174 | -5.03 | 0.477 | -- | -9.00 | -7.92 | -265.14 | -- | -3.59 | -- |
| China Health Group Ltd | 39.87m | -60.77m | 816.87m | 127.00 | -- | -- | -- | 20.49 | -0.1034 | -0.1034 | 0.0722 | -0.0363 | 0.2052 | 2.02 | 1.76 | 269,412.20 | -31.41 | -16.08 | -261.02 | -42.30 | 22.79 | 28.29 | -153.08 | -44.72 | 0.7455 | -22.53 | -- | -- | -35.02 | -2.92 | -68.69 | -- | 30.06 | -- |
| Broncus Holding Corp | 47.51m | -118.41m | 885.49m | 193.00 | -- | 0.7056 | -- | 18.64 | -0.2441 | -0.2441 | 0.0979 | 2.38 | 0.0347 | 0.4314 | 0.855 | 237,540.00 | -8.65 | -44.03 | -8.96 | -46.77 | 72.36 | 76.11 | -249.25 | -849.59 | 26.33 | -- | 0.0003 | -- | -20.71 | 0.1458 | 45.52 | -- | -2.79 | -- |
| Gaush Meditech Ltd | 1.63bn | 115.27m | 1.05bn | 819.00 | 9.03 | 0.5467 | 5.06 | 0.643 | 0.7839 | 0.7839 | 11.09 | 12.95 | 0.535 | 2.08 | 9.05 | 1,842,149.00 | 3.62 | -1.53 | 4.67 | -2.20 | 47.29 | 47.66 | 6.77 | -2.90 | 1.57 | 8.16 | 0.2188 | -- | 1.58 | 5.24 | -46.75 | -- | 79.78 | -- |
| Kaisa Health Group Holdings Ltd | 166.42m | -31.22m | 1.06bn | 917.00 | -- | 2.43 | -- | 6.36 | -0.0062 | -0.0062 | 0.033 | 0.0865 | 0.308 | 6.69 | 1.52 | 193,284.50 | -6.59 | -7.25 | -7.83 | -9.34 | 41.58 | 45.27 | -21.40 | -28.20 | 3.89 | -- | 0.0257 | -- | -0.2824 | -5.93 | -720.72 | -- | -19.69 | -- |
| Venus MedTech HangZhou Inc | 483.35m | -726.97m | 1.23bn | 605.00 | -- | 0.5264 | -- | 2.55 | -1.66 | -1.66 | 1.10 | 5.30 | 0.1218 | 0.9065 | 2.08 | 699,497.60 | -18.34 | -13.83 | -21.01 | -15.57 | 75.83 | 78.74 | -150.57 | -151.55 | 1.56 | -32.63 | 0.1928 | -- | -4.18 | 15.08 | -1.50 | -- | 11.12 | -- |
| Beijing Airdoc Technology Co Ltd | 165.59m | -199.82m | 1.27bn | 193.00 | -- | 0.8886 | -- | 7.64 | -1.95 | -1.95 | 1.62 | 13.90 | 0.1002 | 1.57 | 2.80 | 587,198.80 | -12.54 | -12.40 | -13.31 | -13.54 | 66.29 | 56.72 | -125.12 | -128.07 | 8.71 | -- | 0.0098 | -- | -23.34 | 38.74 | -92.75 | -- | 1.28 | -- |
| Shanghai Bio-heart Biologicl Tech Co Ltd | 23.60m | -101.06m | 1.34bn | 70.00 | -- | 2.48 | -- | 56.73 | -0.4152 | -0.4152 | 0.097 | 2.22 | 0.0251 | 0.8435 | 3.43 | 374,625.70 | -11.04 | -30.86 | -12.96 | -32.99 | 46.47 | -- | -439.71 | -- | 11.95 | -1.47 | 0.203 | -- | -- | -- | 50.00 | -- | 25.75 | -- |
| Cryofocus Medtech (Shanghai) Co Ltd | 96.34m | -85.99m | 1.44bn | 180.00 | -- | 21.68 | -- | 14.99 | -0.3596 | -0.3596 | 0.4029 | 0.2722 | 0.4945 | 1.12 | -- | 349,075.20 | -47.93 | -- | -72.64 | -- | 67.45 | -- | -96.93 | -- | 1.40 | -54.78 | 0.3918 | -- | 30.72 | -- | -7.06 | -- | -- | -- |
| Shanghai HeartCare Medcl Tech Corp Ltd | 378.92m | 48.01m | 1.74bn | 327.00 | 37.03 | 1.41 | 21.16 | 4.59 | 1.24 | 1.24 | 9.93 | 32.47 | 0.2736 | 0.7131 | 3.54 | 1,101,506.00 | 3.47 | -13.27 | 3.66 | -13.97 | 67.49 | 66.65 | 12.67 | -90.50 | 13.16 | -- | 0.0396 | -- | 19.61 | -- | 85.51 | -- | -24.35 | -- |
| Ethk Labs Inc | 3.48bn | 197.13m | 1.86bn | 877.00 | 9.62 | 0.4796 | 7.66 | 0.5343 | 0.1205 | 0.1205 | 2.13 | 2.42 | 0.536 | 1.06 | 6.84 | 4,035,675.00 | 3.08 | 4.60 | 4.86 | 6.04 | 22.94 | 21.71 | 5.74 | 7.17 | 0.5095 | 5.12 | 0.3196 | -- | 2.40 | 6.27 | 9.35 | -1.08 | 10.78 | -- |
| Sisram Medical Ltd | 2.70bn | 160.99m | 1.89bn | 1.04k | 11.73 | 0.5178 | 5.76 | 0.6983 | 0.3437 | 0.3437 | 5.77 | 7.78 | 0.549 | 1.55 | 3.90 | 2,662,970.00 | 3.90 | 5.64 | 4.82 | 6.66 | 60.93 | 58.95 | 7.10 | 9.80 | 1.73 | -- | 0.0879 | 28.86 | -2.83 | 15.01 | -20.23 | 3.87 | 41.74 | 2.81 |
| PW Medtech Group Ltd | 955.80m | 165.81m | 1.97bn | 1.36k | 12.17 | 0.454 | 5.43 | 2.07 | 0.1101 | 0.1101 | 0.6355 | 2.95 | 0.1603 | 2.91 | 11.47 | 675,476.10 | 3.52 | 7.71 | 4.42 | 8.74 | 52.62 | 56.56 | 21.96 | 75.91 | 9.12 | -- | 0.0042 | 8.38 | 13.90 | 16.25 | -1.57 | 12.96 | 8.75 | -- |
Data as of Feb 16 2026. Currency figures normalised to Shanghai Bio-heart Biological Technology Co Ltd's reporting currency: Hong Kong Dollar HKD
6.87%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Principal Global Investors LLCas of 02 Jan 2026 | 15.70m | 6.66% |
| Dimensional Fund Advisors LPas of 30 Nov 2025 | 335.30k | 0.14% |
| China Asset Management (Hong Kong) Ltd.as of 30 Jun 2024 | 120.80k | 0.05% |
| DFA Australia Ltd.as of 31 Dec 2025 | 31.28k | 0.01% |
More ▼
Data from 31 Dec 2025 - 10 Feb 2026Source: FactSet Research Systems Inc.
